Evaluating the Effectiveness of a Novel Systematic Screening Approach for Tuberculosis among Individuals Suspected or Recovered from COVID-19: Experiences from Niger and Guinea
Authors:
- Aboubacar Sidiki MagassoubaAMAboubacar Sidiki Magassouba
- Souleymane Mahamadou BassirouSBSouleymane Mahamadou Bassirou
- Almamy Amara TouréATAlmamy Amara Touré
- Boubacar Djelo DialloBDBoubacar Djelo Diallo
- Soumana AlphazaziSASoumana Alphazazi
- Diao CisséDCDiao Cissé
- Mohamed Sitan KeitaMKMohamed Sitan Keita
- Elhadj Saidou SeyabatouESElhadj Saidou Seyabatou
- Adama Marie BangouraABAdama Marie Bangoura
- Hugues Asken TraoréHTHugues Asken Traoré
- Tom DecrooTDTom Decroo
- Jonathon R. CampbellJCJonathon R. Campbell
Open Access
- 5 September 2022
- journal article
- research article
- Published by MDPI AG in Tropical Medicine and Infectious Disease
- Vol. 7 (9) , 228
Abstract
Evidence suggests that the COVID-19 pandemic negatively impacts tuberculosis (TB) activities. As TB and COVID-19 have similar symptoms, we assessed the effectiveness of integrated TB/COVID-19 screening in Guinea and Niger. From May to December 2020, TB screening was offered to symptomatic patients after a negative COVID-19 PCR test or after recovery from COVID-19 in Guinea. From December 2020 to March 2021, all presumptive COVID-19 patients with respiratory symptoms were tested simultaneously for COVID-19 and TB in Niger. We assessed the TB detection yield and used micro-costing to estimate the costs associated with both screening algorithms. A total of 863 individuals (758 in Guinea, and 105 in Niger), who were mostly male (60%) and with a median age of 34 (IQR: 26–45), were screened for TB. Reported symptoms were cough ≥2 weeks (49%), fever (45%), and weight loss (30%). Overall, 61 patients (7%) tested positive for COVID-19 (13 in Guinea, 48 in Niger) and 43 (4.9%) were diagnosed with TB disease (35 or 4.6% in Guinea, and 8 or 7.6% in Niger). The cost per person initiating TB treatment was USD $367 in Guinea and $566 in Niger. Overall, the yield of both approaches was high, and the cost was modest. Optimizing integrated COVID-19/TB screening may support maintaining TB detection during the ongoing pandemic.Keywords
Funding Information
- The Special Programme for Research and Training in Tropical Medicine (TDR)
- World Health Organization
- the Union, Damien Foundation
- the Access and Delivery Partnership under UNDP
This publication has 19 references indexed in Scilit:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategiesInternational Journal of Antimicrobial Agents, 2020
- Association between tuberculosis and COVID‐19 severity and mortality: A rapid systematic review and meta‐analysisJournal of Medical Virology, 2020
- COVID-19 and Bacillus Calmette-Guérin: What is the Link?European Urology Oncology, 2020
- Predicted impact of the COVID-19 pandemic on global tuberculosis deaths in 2020medRxiv, 2020
- Correction: Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responsesPLOS ONE, 2018
- Implications of the Ebola virus disease outbreak in Guinea: Qualitative findings to inform future health and nutrition-related responsesPLOS ONE, 2018
- Digital CXR with computer aided diagnosis versus symptom screen to define presumptive tuberculosis among household contacts and impact on tuberculosis diagnosisBMC Infectious Diseases, 2017
- Tuberculosis in Adults and Children2015
- The Triad of Weight Loss, Fever and Night Sweating: Isolated Bone Marrow Tuberculosis, a Case ReportJournal of Chemotherapy, 2002
- Routine diagnosis of tuberculosis with phase-contrast microscopy.1974